Prenatal Testing Services Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Diagnostic Type, Disease, End User, and Geography

Description

List of Tables

The prenatal testing services market is projected to reach US$ 1,510.31 million by 2031 from US$ 571.18 million in 2024. The market is projected to register a CAGR of 15.2% from 2025 to 2031. Major factors driving market growth include the increasing demand for NIP testing, surging prevalence of genetic disorders and congenital anomalies, and rising awareness and acceptance of early genetic screening. They are propelling the acceptance of prenatal testing services. Furthermore, integration of whole-genome and multi-omic prenatal tests is expected to drive market growth during the forecast period. However, high cost of advanced tests, lack of data privacy and security, ethical, legal, and cultural concerns are among the market deterrents.

In the US, NIPT is now widely offered and used in clinical practice. Clinical guidelines from the American College of Obstetricians and Gynecologists (ACOG) and the Society for Maternal-Fetal Medicine (SMFM) endorse NIPT as a first-line screening option, regardless of maternal age or risk status. Studies show that after the introduction of NIPT, the rates of invasive diagnostic procedures (such as amniocentesis and CVS) dropped significantly in one analysis, with invasive testing declining by nearly 40% between 2012 and 2015. Research suggests that NIPT has high sensitivity and specificity for common trisomies, resulting in fewer false positives and improved risk stratification. However, genetic counselors and healthcare providers continue to face challenges. The increased use of NIPT brings workload pressures, particularly in ensuring informed consent and post-test counseling. Meanwhile, population-based studies indicate that offering NIPT broadly could reduce the number of invasive procedures and associated pregnancy risks.

The comparative company analysis evaluates and categorizes the prenatal testing services market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report thoroughly examines the recent significant developments and innovations by leading vendors in the global prenatal testing services market. The key market players include Myriad Genetics Inc; Illumina Inc; Thermo Fisher Scientific Inc.; Laboratory Corp of America Holdings; and Fulgent Genetics, Inc.

In terms of diagnostic type, the prenatal testing services market is segmented into noninvasive, invasive. The noninvasive segment held a larger market share in 2024, owing to noninvasive prenatal tests provide a safe and early method for detecting chromosomal abnormalities by analyzing a simple blood sample from the mother. Due to their high precision and minimal risk, these tests are being rapidly adopted, which is leading the prenatal testing services market.

Based on disease, the prenatal testing services market is categorized into aneuploidy, microdeletions, structural chromosomal abnormalities, and others. The aneuploidy segment accounted for the largest share of the Prenatal testing services market in 2024. The aneuploidy prenatal testing market is expanding due to rising maternal age, increased adoption of non-invasive prenatal testing, technological advancements, and growing awareness of genetic disorders, while regulatory and cost challenges persist.

Based on end-user, the prenatal testing services market is segmented into hospitals, diagnostic laboratories, specialty clinics, other end users. The hospitals segment held a larger market share in 2024, owing to the integration of diagnostic services, rising maternal healthcare awareness, the adoption of advanced testing technologies, and an increasing demand for early genetic screening.

Companies operating in the prenatal testing services market adopt various organic and inorganic strategies. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaborations, and partnerships. These growth strategies enable market players to expand their businesses, enhance their geographic presence, and contribute to overall market growth. Furthermore, acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. The following are a few significant developments by key players in the Prenatal testing services market.

In May 2025, Roche announced a collaboration with Broad Clinical Labs to accelerate the adoption of SBX sequencing technology for critically ill newborns, with a focus on integrating whole-genome sequencing into routine clinical practice.

In April 2025, UnitedHealthcare eliminated prior authorization requirements for non-invasive prenatal testing across multiple plans, including commercial and community plans. This policy change affects cell-free fetal DNA testing procedures and aims to simplify access to healthcare for members and providers.

Product Code: TIPRE00042051

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Analyst Market Outlook
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
3.3 Assumptions and Limitations

4. Prenatal Testing Services Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain

5. Prenatal Testing Services Market - Key Market Dynamics

5.1 Prenatal Testing Services Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increasing Demand for Noninvasive Prenatal Testing
- 5.2.2 Surging Prevalence of Genetic Disorders and Congenital Anomalies
- 5.2.3 Rising Awareness and Acceptance of Early Genetic Screening
5.3 Market Restraints
- 5.3.1 High Cost of Advanced Tests
- 5.3.2 Lack of Data Privacy and Security
- 5.3.3 Ethical, Legal, and Cultural Concerns
5.4 Market Opportunities
- 5.4.1 Growth in Emerging Economies
- 5.4.2 Integration of Whole-Genome and Multi-Omic Prenatal Tests
- 5.4.3 Expansion of NIPT into Low-Risk Pregnancies
5.5 Future Trends
- 5.5.1 AI-driven Interpretation and Predictive Analytics
- 5.5.2 At-home Sample Collection and Decentralized Testing Models
- 5.5.3 Rising Adoption of Comprehensive cfDNA Panels
5.6 Impact of Drivers and Restraints:

6. Prenatal Testing Services Market - Global Market Analysis

6.1 Prenatal Testing Services Market Revenue (US$ Million), 2021-2031
6.2 Prenatal Testing Services Market Forecast Analysis

7. Prenatal Testing Services Market Analysis - by Diagnostic Type

7.1 Non Invasive
- 7.1.1 Overview
- 7.1.2 Non Invasive: Prenatal Testing Services Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Invasive
- 7.2.1 Overview
- 7.2.2 Invasive: Prenatal Testing Services Market - Revenue and Forecast to 2031 (US$ Million)

8. Prenatal Testing Services Market Analysis - by Disease

8.1 Aneuploidy
- 8.1.1 Overview
- 8.1.2 Aneuploidy: Prenatal Testing Services Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Microdeletions
- 8.2.1 Overview
- 8.2.2 Microdeletions: Prenatal Testing Services Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Structural Chromosomal Abnormalities
- 8.3.1 Overview
- 8.3.2 Structural Chromosomal Abnormalities: Prenatal Testing Services Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Others
- 8.4.1 Overview
- 8.4.2 Others: Prenatal Testing Services Market - Revenue and Forecast to 2031 (US$ Million)

9. Prenatal Testing Services Market Analysis - by End User

9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: Prenatal Testing Services Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Diagnostic Laboratories
- 9.2.1 Overview
- 9.2.2 Diagnostic Laboratories: Prenatal Testing Services Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Specialty Clinics
- 9.3.1 Overview
- 9.3.2 Specialty Clinics: Prenatal Testing Services Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Other End Users
- 9.4.1 Overview
- 9.4.2 Other End Users: Prenatal Testing Services Market - Revenue and Forecast to 2031 (US$ Million)

10. Prenatal Testing Services Market - Geographical Analysis

10.1 North America
- 10.1.1 North America Prenatal Testing Services Market Overview
- 10.1.2 North America: Prenatal Testing Services Market - Revenue, 2021-2031 (US$ Million)
  - 10.1.2.1 North America: Prenatal Testing Services Market - Revenue and Forecast Analysis - by Diagnostic Type
  - 10.1.2.2 North America: Prenatal Testing Services Market - Revenue and Forecast Analysis - by Disease
  - 10.1.2.3 North America: Prenatal Testing Services Market - Revenue and Forecast Analysis - by End User
- 10.1.3 North America: Prenatal Testing Services Market - Revenue and Forecast Analysis - by Country
  - 10.1.3.1 United States: Prenatal Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.3.1.1 United States: Prenatal Testing Services Market Breakdown, by Diagnostic Type
    - 10.1.3.1.2 United States: Prenatal Testing Services Market Breakdown, by Disease
    - 10.1.3.1.3 United States: Prenatal Testing Services Market Breakdown, by End User
  - 10.1.3.2 Canada: Prenatal Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.3.2.1 Canada: Prenatal Testing Services Market Breakdown, by Diagnostic Type
    - 10.1.3.2.2 Canada: Prenatal Testing Services Market Breakdown, by Disease
    - 10.1.3.2.3 Canada: Prenatal Testing Services Market Breakdown, by End User
  - 10.1.3.3 Mexico: Prenatal Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.3.3.1 Mexico: Prenatal Testing Services Market Breakdown, by Diagnostic Type
    - 10.1.3.3.2 Mexico: Prenatal Testing Services Market Breakdown, by Disease
    - 10.1.3.3.3 Mexico: Prenatal Testing Services Market Breakdown, by End User
10.2 Europe
- 10.2.1 Europe Prenatal Testing Services Market Overview
- 10.2.2 Europe: Prenatal Testing Services Market - Revenue, 2021-2031 (US$ Million)
  - 10.2.2.1 Europe: Prenatal Testing Services Market - Revenue and Forecast Analysis - by Diagnostic Type
  - 10.2.2.2 Europe: Prenatal Testing Services Market - Revenue and Forecast Analysis - by Disease
  - 10.2.2.3 Europe: Prenatal Testing Services Market - Revenue and Forecast Analysis - by End User
- 10.2.3 Europe: Prenatal Testing Services Market - Revenue and Forecast Analysis - by Country
  - 10.2.3.1 Germany: Prenatal Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.1.1 Germany: Prenatal Testing Services Market Breakdown, by Diagnostic Type
    - 10.2.3.1.2 Germany: Prenatal Testing Services Market Breakdown, by Disease
    - 10.2.3.1.3 Germany: Prenatal Testing Services Market Breakdown, by End User
  - 10.2.3.2 United Kingdom: Prenatal Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.2.1 United Kingdom: Prenatal Testing Services Market Breakdown, by Diagnostic Type
    - 10.2.3.2.2 United Kingdom: Prenatal Testing Services Market Breakdown, by Disease
    - 10.2.3.2.3 United Kingdom: Prenatal Testing Services Market Breakdown, by End User
  - 10.2.3.3 France: Prenatal Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.3.1 France: Prenatal Testing Services Market Breakdown, by Diagnostic Type
    - 10.2.3.3.2 France: Prenatal Testing Services Market Breakdown, by Disease
    - 10.2.3.3.3 France: Prenatal Testing Services Market Breakdown, by End User
  - 10.2.3.4 Italy: Prenatal Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.4.1 Italy: Prenatal Testing Services Market Breakdown, by Diagnostic Type
    - 10.2.3.4.2 Italy: Prenatal Testing Services Market Breakdown, by Disease
    - 10.2.3.4.3 Italy: Prenatal Testing Services Market Breakdown, by End User
  - 10.2.3.5 Spain: Prenatal Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.5.1 Spain: Prenatal Testing Services Market Breakdown, by Diagnostic Type
    - 10.2.3.5.2 Spain: Prenatal Testing Services Market Breakdown, by Disease
    - 10.2.3.5.3 Spain: Prenatal Testing Services Market Breakdown, by End User
  - 10.2.3.6 Rest of Europe: Prenatal Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.6.1 Rest of Europe: Prenatal Testing Services Market Breakdown, by Diagnostic Type
    - 10.2.3.6.2 Rest of Europe: Prenatal Testing Services Market Breakdown, by Disease
    - 10.2.3.6.3 Rest of Europe: Prenatal Testing Services Market Breakdown, by End User
10.3 Asia Pacific
- 10.3.1 Asia Pacific Prenatal Testing Services Market Overview
- 10.3.2 Asia Pacific: Prenatal Testing Services Market - Revenue, 2021-2031 (US$ Million)
  - 10.3.2.1 Asia Pacific: Prenatal Testing Services Market - Revenue and Forecast Analysis - by Diagnostic Type
  - 10.3.2.2 Asia Pacific: Prenatal Testing Services Market - Revenue and Forecast Analysis - by Disease
  - 10.3.2.3 Asia Pacific: Prenatal Testing Services Market - Revenue and Forecast Analysis - by End User
- 10.3.3 Asia Pacific: Prenatal Testing Services Market - Revenue and Forecast Analysis - by Country
  - 10.3.3.1 China: Prenatal Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.1.1 China: Prenatal Testing Services Market Breakdown, by Diagnostic Type
    - 10.3.3.1.2 China: Prenatal Testing Services Market Breakdown, by Disease
    - 10.3.3.1.3 China: Prenatal Testing Services Market Breakdown, by End User
  - 10.3.3.2 Japan: Prenatal Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.2.1 Japan: Prenatal Testing Services Market Breakdown, by Diagnostic Type
    - 10.3.3.2.2 Japan: Prenatal Testing Services Market Breakdown, by Disease
    - 10.3.3.2.3 Japan: Prenatal Testing Services Market Breakdown, by End User
  - 10.3.3.3 India: Prenatal Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.3.1 India: Prenatal Testing Services Market Breakdown, by Diagnostic Type
    - 10.3.3.3.2 India: Prenatal Testing Services Market Breakdown, by Disease
    - 10.3.3.3.3 India: Prenatal Testing Services Market Breakdown, by End User
  - 10.3.3.4 Australia: Prenatal Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.4.1 Australia: Prenatal Testing Services Market Breakdown, by Diagnostic Type
    - 10.3.3.4.2 Australia: Prenatal Testing Services Market Breakdown, by Disease
    - 10.3.3.4.3 Australia: Prenatal Testing Services Market Breakdown, by End User
  - 10.3.3.5 South Korea: Prenatal Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.5.1 South Korea: Prenatal Testing Services Market Breakdown, by Diagnostic Type
    - 10.3.3.5.2 South Korea: Prenatal Testing Services Market Breakdown, by Disease
    - 10.3.3.5.3 South Korea: Prenatal Testing Services Market Breakdown, by End User
  - 10.3.3.6 Rest of APAC: Prenatal Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.6.1 Rest of APAC: Prenatal Testing Services Market Breakdown, by Diagnostic Type
    - 10.3.3.6.2 Rest of APAC: Prenatal Testing Services Market Breakdown, by Disease
    - 10.3.3.6.3 Rest of APAC: Prenatal Testing Services Market Breakdown, by End User
10.4 Middle East and Africa
- 10.4.1 Middle East and Africa Prenatal Testing Services Market Overview
- 10.4.2 Middle East and Africa: Prenatal Testing Services Market - Revenue, 2021-2031 (US$ Million)
  - 10.4.2.1 Middle East and Africa: Prenatal Testing Services Market - Revenue and Forecast Analysis - by Diagnostic Type
  - 10.4.2.2 Middle East and Africa: Prenatal Testing Services Market - Revenue and Forecast Analysis - by Disease
  - 10.4.2.3 Middle East and Africa: Prenatal Testing Services Market - Revenue and Forecast Analysis - by End User
- 10.4.3 Middle East and Africa: Prenatal Testing Services Market - Revenue and Forecast Analysis - by Country
  - 10.4.3.1 Saudi Arabia: Prenatal Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.3.1.1 Saudi Arabia: Prenatal Testing Services Market Breakdown, by Diagnostic Type
    - 10.4.3.1.2 Saudi Arabia: Prenatal Testing Services Market Breakdown, by Disease
    - 10.4.3.1.3 Saudi Arabia: Prenatal Testing Services Market Breakdown, by End User
  - 10.4.3.2 South Africa: Prenatal Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.3.2.1 South Africa: Prenatal Testing Services Market Breakdown, by Diagnostic Type
    - 10.4.3.2.2 South Africa: Prenatal Testing Services Market Breakdown, by Disease
    - 10.4.3.2.3 South Africa: Prenatal Testing Services Market Breakdown, by End User
  - 10.4.3.3 United Arab Emirates: Prenatal Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.3.3.1 United Arab Emirates: Prenatal Testing Services Market Breakdown, by Diagnostic Type
    - 10.4.3.3.2 United Arab Emirates: Prenatal Testing Services Market Breakdown, by Disease
    - 10.4.3.3.3 United Arab Emirates: Prenatal Testing Services Market Breakdown, by End User
  - 10.4.3.4 Rest of Middle East and Africa: Prenatal Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.3.4.1 Rest of Middle East and Africa: Prenatal Testing Services Market Breakdown, by Diagnostic Type
    - 10.4.3.4.2 Rest of Middle East and Africa: Prenatal Testing Services Market Breakdown, by Disease
    - 10.4.3.4.3 Rest of Middle East and Africa: Prenatal Testing Services Market Breakdown, by End User
10.5 South and Central America
- 10.5.1 South and Central America Prenatal Testing Services Market Overview
- 10.5.2 South and Central America: Prenatal Testing Services Market - Revenue, 2021-2031 (US$ Million)
  - 10.5.2.1 South and Central America: Prenatal Testing Services Market - Revenue and Forecast Analysis - by Diagnostic Type
  - 10.5.2.2 South and Central America: Prenatal Testing Services Market - Revenue and Forecast Analysis - by Disease
  - 10.5.2.3 South and Central America: Prenatal Testing Services Market - Revenue and Forecast Analysis - by End User
- 10.5.3 South and Central America: Prenatal Testing Services Market - Revenue and Forecast Analysis - by Country
  - 10.5.3.1 Brazil: Prenatal Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.5.3.1.1 Brazil: Prenatal Testing Services Market Breakdown, by Diagnostic Type
    - 10.5.3.1.2 Brazil: Prenatal Testing Services Market Breakdown, by Disease
    - 10.5.3.1.3 Brazil: Prenatal Testing Services Market Breakdown, by End User
  - 10.5.3.2 Argentina: Prenatal Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.5.3.2.1 Argentina: Prenatal Testing Services Market Breakdown, by Diagnostic Type
    - 10.5.3.2.2 Argentina: Prenatal Testing Services Market Breakdown, by Disease
    - 10.5.3.2.3 Argentina: Prenatal Testing Services Market Breakdown, by End User
  - 10.5.3.3 Rest of South and Central America: Prenatal Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.5.3.3.1 Rest of South and Central America: Prenatal Testing Services Market Breakdown, by Diagnostic Type
    - 10.5.3.3.2 Rest of South and Central America: Prenatal Testing Services Market Breakdown, by Disease
    - 10.5.3.3.3 Rest of South and Central America: Prenatal Testing Services Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis by Key Players
11.2 Company Market Share Analysis, 2024

12. Industry Landscape

12.1 Overview
12.2 Market Initiative

13. Company Profiles

13.1 Quest Diagnostics Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Myriad Genetics Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Illumina Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Laboratory Corp of America Holdings
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 F. Hoffmann-La Roche Ltd
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Eurofins Scientific SE
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Fulgent Genetics, Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 MedGenome Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Exact Sciences Corp
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Revvity Inc
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners
14.2 List of Abbreviations